Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
Top Cited Papers
- 26 January 2016
- journal article
- research article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 56, 77-84
- https://doi.org/10.1016/j.ejca.2015.12.015
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1Neuro-Oncology, 2012
- Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problemsActa Neuropathologica, 2012
- Malignant Peripheral Nerve Sheath Tumors: Differentiation Patterns and Immunohistochemical Features - A Mini-Review and Our New FindingsJournal of Cancer, 2012
- Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor OutcomeAnnals of Surgery, 2009
- Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated TumoursSarcoma, 2009
- Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1Journal of Medical Genetics, 2007
- Neurofibromatosis 1European Journal of Human Genetics, 2006
- Malignant peripheral nerve sheath tumorsCancer, 2006
- Novel and recurrent mutations in theNF1 gene in Italian patients with neurofibromatosis type 1Human Mutation, 2004
- A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity.Journal of Medical Genetics, 1989